1 / 20

Division of Diabetes Translation

Division of Diabetes Translation. Office of the Director Director: Ann Albright, Ph.D., R.D. Deputy Director: Angela Green-Phillips, M.P.A. Associate Director for Science: Lawrence Barker, Ph.D. Policy and Program Information Team Team Lead: Karen Richard-Lee, M.P.A.

boaz
Download Presentation

Division of Diabetes Translation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Division of Diabetes Translation Office of the Director Director: Ann Albright, Ph.D., R.D. Deputy Director: Angela Green-Phillips, M.P.A. Associate Director for Science: Lawrence Barker, Ph.D Policy and Program Information Team Team Lead: Karen Richard-Lee, M.P.A. Communication & Partnership Team Team Lead: Laura Zauderer, M.P.H. Primary Prevention Initiative Team Program and Policy Coordinator: Russell Sniegowski, M.P.H. Senior Science Consultant: David F. Williamson, Ph.D. Health Disparities Coordination Coordinator: Regina Hardy, B.A., M.S. Administrative Services Administrative Officer: Bonita Foley Epidemiology and Statistics Branch Branch Chief: Edward Gregg, Ph.D. Associate Branch Chief: Desmond Williams, M.D., Ph.D. Program and Evaluation Branch Branch Chief: Barbara Park, R.D.H., M.P.H. Deputy Branch Chief: Patricia Mitchell, M.P.H. Program Admin Coordination (PAC) TeamTeam Lead: Patricia Mitchell, M.P.H. Epidemiology Team Team Lead: Guissepina Imperatore, M.D., Ph.D. Economics Team Team Lead: Ping Zhang, Ph.D. Native Diabetes Wellness Program (NDWP) Team Lead: Dawn Satterfield, R.N., Ph.D. National Diabetes Education Program (NDEP) Director: Judith McDivitt, Ph.D. Deputy Director: Betsy Rodriguez, B.S.N., M.S.N. Vision Health Team Team Lead: Jinan Saaddine, M.D., M.P.H. Surveillance Team Team Lead: Linda Geiss, M.A. Evaluation Team Acting Team Lead: Barbara Park, R.D.H., M.P.H. State Consultation Team Senior Team Lead: Patricia Schumacher, M.S., R.D. Team Lead: Andy Lanza, M.P.H., M.S.W. Team Lead: Wayne Millington, M.P.A. Statistics Team Team Lead: Ted Thompson, M.S. Chronic Kidney Disease Team Team Lead: Desmond Williams, M.D., Ph.D. CS205388-A

  2. DDT Strategic Plan Goals • Prevent diabetes • Prevent complications, disabilities and burden associated with diabetes • Eliminate diabetes-related health disparities • Maximize organizational capability to achieve goals • Build capacity for communication, evaluation, marketing, policy, and partnerships • Create and implement mgmt plan for leadership development, workforce development, and diversity

  3. Division of Diabetes Translation • Tracking the disease burden • Conducting applied translation research to prioritize effective interventions • Economic analyses • Developing and maintaining state-based diabetes prevention and control programs • Implementing National Program Initiatives: • National Diabetes Education Program • Native Diabetes Wellness Program

  4. Diabetes Prevention and Control Programs 50 States & DC 8 Territories 17 Tribes Vulnerable Pops

  5. National Diabetes Education Program* *NDEP is a joint initiative of CDC and NIH

  6. Using Core Public Health Functionsand the 10 Essential Public Health ServicesThe Role of DPCP’s Diabetes Surveillance Workforce Development Assessment & Strategic Planning Quality Care Improvement Technical Assistance Partnership Development Raising the Profile of Diabetes

  7. Surveillance Observational and Clinical Epidemiology Health Services And Policy Research Economic and Cost- Effectiveness Research • TRIAD Study • NDSS • VH Initiative • CKD Program • Access to care • National Surveillance System • Risk Factors • Prevalence / Incidence • Complications • Care and treatment • Small Area Methods • SEARCH • Modeling / Forecasting • Vision Health Initiative (VHI) • CKD Program • Lifestyle Interventions • Body Composition • Risk Identification tools • Da Qing Follow-up • NIH Collaborative Trials • SES Disparities • Life stages (youth / aging) • Modeling / Forecasting • Cost- effectiveness Studies • DPP-OS • Look AHEAD • ACCORD • Vision Health Initiative • Chronic Kidney Disease Program

  8. Hospitals Household Surveys CDC National Diabetes Surveillance System Vital statistics Telephone Surveys Registries

  9. Analytic Applications of U.S. National Diabetes Surveillance System • Characterizing diabetes epidemic, its risk factors and impact. • Identifying key at-risk populations. • Modeling the disease and cost impact over time and lifetime. • Setting and monitoring national health objectives. • Investigating new threats. • National Diabetes Fact Sheet

  10. Small Area Estimates

  11. Effectiveness Studies • NEXT-D (Natural Experiments in Translation for Diabetes) • DaQing Follow-up Study • U.S. Mexico Border Project • TRIAD (Translating Research into Action for Diabetes) • Diabetes Prevention Program (DPPOS) • Look AHEAD Study • ACCORD Study

  12. New Research Initiatives • NEXT-D (Natural Experiments in Translation for Diabetes) • Vision Health Initiative Translation Research Centers • Advances in Surveillance • Small Area • State-based Incidence • Revised Disease Forecasting • Incidence • Cost • Intervention Effectiveness • National Primary Prevention registry and evaluation

  13. Natural Experiments and Effectiveness Studies of Population-Targeted Policies for Diabetes Prevention and Control • The Diabetes Health Plan: A System-Level Intervention to Prevent and Treat Diabetes • University of California Los Angeles • Principal Investigator: Dr. Carol Mangione • Effectiveness of a National Health Care Community Partnership to Prevent Diabetes • Indiana University • Principal Investigator: Dr. Ron Ackermann • The Impact of Emerging Health Insurance Designs on Diabetes Outcomes and Disparities • Harvard Pilgrim Health Care and Harvard University • Principal Investigator: Dr. Dennis Ross-Degnan • Learnings in Diabetes Prevention from an Integrated Delivery System • Kaiser Foundation Research Institute • Principal Investigator: Dr. Joe Selby • Management and Education for Diabetes in New York City • St. Luke’s-Roosevelt Institute for Health Sciences • Principal Investigator: Dr. Jeanine Albu

  14. Policies and Interventions Proposed in Phase I Studies • Employer-based detection, outreach, incentives, and telephone coaching for primary prevention among 3750 high risk adults from 5 employers. • Disease-specific health insurance product; reduced copayments, and incentives among 136,000. • Impact of reduced copayments and incentives among adults with diabetes and pre-diabetes from 15 large employers. • Systematic post-partum screening of women with GDM.

  15. Policies and Interventions Proposed in Phase I Studies • Enhanced EMR with decision support for diabetes care, screening, and prevention referral among 4000 adults with DM and pre-DM; • Impact of employer-mandated switch to high deductibleand “consumer-driven” health plans among 62,000 diabetic adults age 18-64. • Health plan administered diabetes prevention programs delivered in YMCAs on 7500 high risk adults. • Pre-diabetes screening and referral to multi-tiered interventions.

  16. Attributes of Studies • Population targeted policies and interventions from 3 sources: • Health Systems; • Business and community organizations; • Government agencies • Ongoing or imminent interventions with cost of intervention underwritten by other sources. • Aimed at prevention of diabetes and/or its complications.

  17. Primary Funding Mechanisms • Grants • Cooperative Agreements • Contracts • State DPCPs

More Related